Göran Forsberg
Holds a PhD in Technology from KTH and is an Associate Professor at Lund University. Dr Forsberg has more than 35 years of experience in pharmaceutical development within both the biotech industry and large pharmaceutical companies, with extensive expertise in various aspects of drug development, as well as business development and investor relations. Göran Forsberg served as CEO of Cantargia AB from 2014 to February 2025. Prior to that, he worked as Head of Business Development at Active Biotech.
Our team
Moa Fransson
Cecilia Drakskog
Gerald Pettersson
Jenny Lundell
Liselotte Larsson
Jonas Gibson
Johan Lund
Carl-Henrik Heldin
Åsa Wallin
Miyuki Shimane
Bengt Westermark
Göran Forsberg